Loading stock data…
Electromed (ELMD)
$27.10-0.90 (-3.21%)
Market OpenUpdated 11:12 AM EDT
Electromed, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Electromed, Inc. in the Healthcare sector is trading at $27.51 with a market capitalization of $308M. Wall Street consensus targets $48.50 (2 analysts), implying a +76.3% move over the next 12 months. The stock is currently near its 52-week low of $23.01, remaining 12.4% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 13 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +76.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 13) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $18.57M↓ | $18.90M↑ | $16.89M↓ | $17.39M↑ | $15.68M |
| Gross Profit | $14.64M↓ | $14.82M↑ | $13.20M↓ | $13.62M↑ | $12.23M |
| Operating Income | $3.77M↑ | $3.62M↑ | $2.67M↓ | $3.04M↑ | $2.14M |
| Net Income | $3.00M↑ | $2.76M↑ | $2.14M↓ | $2.20M↑ | $1.89M |
Peer Comparison
JNJUNHPFE
Fundamentals
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The co...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$307.94M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
20.55%
Volume
Today's trading volume
25,493
Recent News
Electromed (ELMD) Keeps Growing While Wall Street Barely Notices
On August 25, Electromed (NASDAQ:ELMD) reported fiscal fourth-quarter results that extended a streak few small-cap medical device companies can claim: fifteen consecutive quarters of year-over-year revenue and profit growth. Net revenue hit a record $19.4 million, up 11.6% from a year earlier, and diluted earnings per share climbed to $0.39 from $0.25. Those headline numbers […]
Electromed (ELMD) Q4 2026 Earnings Call Transcript
Home care revenue surged 15.2% as sales rep productivity hit record levels.
Electromed, Inc. Q4 2026 Earnings Call Summary
Moby summary of Electromed, Inc.'s Q4 2026 earnings call
Electromed Inc (ELMD) (Q4 2026) Earnings Call Highlights: Record Revenue and 15th Consecutive ...
Electromed Inc (ELMD) delivers record Q4 revenue of $19.4 million, up 11.6% year-over-year, with full-year EPS reaching $1.30 per diluted share.
Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
Electromed (ELMD) delivered earnings and revenue surprises of +21.88% and -2.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?